To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

Bernstein analyst Callum Elliott downgraded Reckitt (RKT – Research Report) to a Hold today and set a price target of £53.00. The ...

In a stunning turnaround for Abbott Laboratories and Mead Johnson, a formidable team of women lawyers has secured a crucial ...

Abbott and Reckitt's Mead Johnson secured a lawsuit win regarding infant formulas, causing Abbott's shares to rise 5%. Their ...

The lawsuit alleged that Mead Johnson, which makes baby formula, had failed to warn that its products could cause the illness ...

In company news, Reckitt Benckiser was among the day’s strongest performers as investors reacted to a favourable court ruling ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

London stocks closed higher on Friday, as investors digested an unexpectedly low US payrolls figure, as well as a range of UK economic releases.

Reckitt Benckiser surged to the top of the index after its subsidiary Mead Johnson was cleared of liability in a US trial ...

Reckitt shares topped the Stoxx Europe 600 index in early European trade, rising around 10%, the company's biggest one-day gain in 16 years. Shares in New York-listed Abbott were up 3.9%.

Harvey Jones rejected any thought of buying this former FTSE 100 darling in August but after some positive news should he now ...